Donald Allen Williams - Oct 6, 2025 Form 4/A - Amendment Insider Report for PALISADE BIO, INC. (PALI)

Role
Director
Signature
/s/ Ryker Willie, Attorney-in-Fact
Stock symbol
PALI
Transactions as of
Oct 6, 2025
Transactions value $
$0
Form type
4/A - Amendment
Date filed
11/6/2025, 08:21 PM
Date Of Original Report
Oct 8, 2025
Previous filing
Sep 5, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Williams Donald Allen Director 1902 WRIGHT PLACE, SUITE 200, CARLSBAD /s/ Ryker Willie, Attorney-in-Fact 2025-11-06 0001620013

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PALI Restricted Stock Units Award $0 +182K $0.00 182K Oct 6, 2025 Common Stock 182K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan (the "Plan") to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash.
F2 This amended Form 4 is being filed to correct the previously reported grant amount of 1,538,700 RSUs to the Reporting Person. The Issuer has rescinded the grant of 1,356,700 RSUs of the previously reported grant of 1,538,700 RSUs.
F3 The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date.